BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 21915121)

  • 1. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.
    Villano JL; Koshy M; Shaikh H; Dolecek TA; McCarthy BJ
    Br J Cancer; 2011 Oct; 105(9):1414-8. PubMed ID: 21915121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial differences in primary central nervous system lymphoma incidence and survival rates.
    Pulido JS; Vierkant RA; Olson JE; Abrey L; Schiff D; O'Neill BP
    Neuro Oncol; 2009 Jun; 11(3):318-22. PubMed ID: 19273630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in primary central nervous system lymphoma incidence and survival in the U.S.
    Shiels MS; Pfeiffer RM; Besson C; Clarke CA; Morton LM; Nogueira L; Pawlish K; Yanik EL; Suneja G; Engels EA
    Br J Haematol; 2016 Aug; 174(3):417-24. PubMed ID: 27018254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades.
    Mendez JS; Ostrom QT; Gittleman H; Kruchko C; DeAngelis LM; Barnholtz-Sloan JS; Grommes C
    Neuro Oncol; 2018 Apr; 20(5):687-694. PubMed ID: 29036697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unequal Cumulative Incidence and Mortality Outcome in Childhood Brain and Central Nervous System Malignancy in the USA.
    Holmes L; Chavan P; Blake T; Dabney K
    J Racial Ethn Health Disparities; 2018 Oct; 5(5):1131-1141. PubMed ID: 29516435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain, other central nervous system, and eye cancer.
    Polednak AP; Flannery JT
    Cancer; 1995 Jan; 75(1 Suppl):330-7. PubMed ID: 8001004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients.
    Mahale P; Shiels MS; Lynch CF; Engels EA
    Am J Transplant; 2018 Feb; 18(2):453-461. PubMed ID: 28805292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing incidence rates of primary central nervous system lymphoma.
    Kadan-Lottick NS; Skluzacek MC; Gurney JG
    Cancer; 2002 Jul; 95(1):193-202. PubMed ID: 12115333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma.
    O'Neill BP; Decker PA; Tieu C; Cerhan JR
    Am J Hematol; 2013 Dec; 88(12):997-1000. PubMed ID: 23873804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013.
    Eloranta S; Brånvall E; Celsing F; Papworth K; Ljungqvist M; Enblad G; Ekström-Smedby K
    Eur J Haematol; 2018 Jan; 100(1):61-68. PubMed ID: 28983970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences.
    Wu XC; Andrews P; Chen VW; Groves FD
    Cancer Epidemiol; 2009 Nov; 33(5):337-46. PubMed ID: 19853554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
    Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology series of brain-related disorders in Mongolia: nationwide registry-based epidemiological study on CNS tumours in Mongolia, 2015-2019.
    Sandagdorj T; Tudev U; Jamiyandorj O; Oka T; Lkhagvasuren B
    J Integr Neurosci; 2022 Jan; 21(1):24. PubMed ID: 35164460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
    van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
    Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Hodgkin's lymphoma: an analysis of the Metropolitan Detroit SEER database.
    Varterasian ML; Graff JJ; Severson RK; Weiss L; al-Katib AM; Kalemkerian GP
    Cancer Invest; 2000; 18(4):303-8. PubMed ID: 10808365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.
    Ostrom QT; Patil N; Cioffi G; Waite K; Kruchko C; Barnholtz-Sloan JS
    Neuro Oncol; 2020 Oct; 22(12 Suppl 2):iv1-iv96. PubMed ID: 33123732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.
    Ostrom QT; Cioffi G; Gittleman H; Patil N; Waite K; Kruchko C; Barnholtz-Sloan JS
    Neuro Oncol; 2019 Nov; 21(Suppl 5):v1-v100. PubMed ID: 31675094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.
    Olson JE; Janney CA; Rao RD; Cerhan JR; Kurtin PJ; Schiff D; Kaplan RS; O'Neill BP
    Cancer; 2002 Oct; 95(7):1504-10. PubMed ID: 12237919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT.
    Truitt G; Gittleman H; Leece R; Ostrom QT; Kruchko C; Armstrong TS; Gilbert MR; Barnholtz-Sloan JS
    J Neurooncol; 2019 Aug; 144(1):53-63. PubMed ID: 31209773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.